Drug intelligence / Profile preview

PASCALLERG

Development stage
Unknown
Lead developer
Pascoe Naturmedizin
Administration
Oral
01

Overview

**PASCALLERG** is a homeopathic combination product formulated to relieve symptoms of *hay fever* and a wide range of other *allergies*, including sneezing, wheezing, dyspnea, itching of the skin, and eye irritation. It is designed as a non-drowsy, gentle alternative to antihistamines and conventional allergy medications, and is suitable for both children (ages 1+) and adults. The homeopathic tablets contain: - Chromium kali sulphuricum Trit. 2X (25 mg) - Acidum formicicum Trit. 2X (2.5 mg) - Gelsemium sempervirens Trit. 2X (2.5 mg) Common indications include seasonal allergies (pollen, ragweed), allergic rhinitis, and reactions from animal dander, dust, foods, insect stings, medicines, and chemicals. The mechanism of action is consistent with general homeopathic principles—purportedly stimulating the body’s self-healing response—rather than a defined pharmacological target. PASCALLERG acts as a symptom reliever, not an immunotherapy, antihistamine, or decongestant[1][2][3][5][6].

Brand names
PASCALLERG
Other names
PASCALLERGPascoe Pascallerg

Beyond the preview

Go deeper on PASCALLERG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PASCALLERG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call